Methylprednisolone (Surgical — Anti-Inflammatory)
Brand names: Solu-Medrone, Depo-Medrone
Methylprednisolone is a potent intermediate-acting corticosteroid used in the surgical setting for its anti-inflammatory and immunosuppressive effects, for example to reduce post-operative inflammation, swelling and oedema.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds glucocorticoid receptors to modulate gene transcription, suppressing the synthesis of inflammatory mediators and reducing oedema, capillary permeability and the inflammatory response.
Prescribing in practice
- Corticosteroids impair wound healing, raise blood glucose and increase infection risk, so weigh these against benefit, screen for active infection, and never stop chronic corticosteroid therapy abruptly because of adrenal suppression.
- Use the lowest effective dose for the shortest period; rapid intravenous administration of large doses has been associated with cardiovascular effects and should be given slowly.
- Provide stress-dose cover for patients on long-term steroids undergoing surgery, and arrange a taper rather than abrupt withdrawal after prolonged courses.
Monitoring
Monitor blood glucose, blood pressure, signs of infection and wound healing, with consideration of adrenal function after prolonged or high-dose use.
Counselling the patient
- Explain a steroid is being used to reduce inflammation and swelling around your operation.
- If you take steroids regularly, do not stop them suddenly and carry your steroid card.
Evidence & guidelines
Methylprednisolone is a well-established corticosteroid; perioperative use is guided by the SPC and surgical practice, balancing anti-inflammatory benefit against effects on healing, glycaemia and infection.
Reference: RCUK Perioperative Steroid Guidelines 2020; NICE NG158; AOSpine Guidelines on Spinal Cord Injury 2017; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk
- Caprini Score for VTE Risk (2005) · VTE Risk
- EuroSCORE II · Surgical Risk
- Thakar Score for AKI after Cardiac Surgery · Surgical Risk
- Major Trauma — Primary Survey (ATLS) · ATLS 10th Edition; JRCALC; NICE NG39
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Burns — TBSA Estimation & Fluid Resuscitation · British Burn Association; EMSB; RCEM 2024
- Lower Gastrointestinal Bleed · NICE; BSG; ACPGBI — Commissioning Guide
- Acute Pancreatitis · NICE; IAP/APA; ACPGBI — CG104
- Hypertrophic Pyloric Stenosis · BAPS / RCPCH